He is also the co-director of the Developmental Therapeutics Fellowship program of the division of hematology-oncology at the Northwestern University Feinberg School of Medicine. His primary focus is on designing and conducting innovative early-phase clinical trials and translational medicine research.
Chae is in charge of many targeted therapy clinical trials, immunotherapy combination trials, and biomarker studies within and outside Northwestern University. He believes that his clinic is his lab and wants to bridge the gap between cutting-edge science and clinical medicine. Above all, his passion is to help desperate patients including those with rare cancers who do not have standard-of-care treatment options or have become refractory to all existing treatment options with novel treatments through well-designed clinical trials bringing the best science to patients.
Chae plans to facilitate the incorporation of novel translational science into high-impact clinical trials. Howard K. Koh is the Harvey V. He served as the The 14th United States Asst. He has received over 70 awards and honors for interdisciplinary accomplishments in medicine and public health including six honorary doctorate degrees, the Dr. Martin Luther King Jr. In , HHS established the annual Dr. He and his wife Dr Claudia Arrigg are the proud parents of three adult children and the proud grandparents of five grandchildren.
Cho is board-certified in interventional cardiology, cardiovascular medicine, and internal medicine. Cho received her undergraduate degree in interdisciplinary studies from the University of California, Los Angeles, graduating cum laude.
Her clinical training continued when she accepted a fellowship in cardiology, followed by a fellowship in interventional cardiology and peripheral disease, both from Cleveland Clinic. I have been a proud KAMA member since After receiving his B. He specializes in the management of patients with liver diseases including patients with cirrhosis and those who may need liver transplantation. Choi is passionate about providing accessible, world-class liver care to the local Asian community, and has a special interest in the care of patients with hepatocellular carcinoma.
